摘要
目的:探讨HIV抗体初筛阳性标本的复检与确证试验结果之间的关系。方法:对2011年1月至2017年10月HIV抗体初筛阳性标本按照《全国艾滋病检测技术规范(2009年、2015年修订版)》要求分别采用酶联免疫吸附试验(ELISA)和胶体硒法进行复检,复检任一方法阳性采用Western blot法进行确证,收集数据进行分析。结果:656份HIV抗体初筛阳性标本,622份复检阳性,初筛假阳性率为5.2%(34/656)。其中受检者信息齐全的490份标本进行确证试验,确证阳性标本450份(91.8%),阴性11份(2.3%),不确定29份(5.9%)。ELISA法复检阳性标本确证阳性率为92.9%(450/488),胶体硒法复检阳性标本确证阳性率为99.1%(450/454),差异有统计学意义(χ~2=31.22,P<0.01);ELISA法中S/CO值>6组与3≤S/CO值≤6组和1≤S/CO值<3组的确证阳性率比较差异均有统计学意义(χ~2=96.33、301.15,P<0.01);ELISA法S/CO值与确证阳性标本出现条带数量呈正相关,Gamma系数为0.788。结论:采用优先选择胶体硒法+ELISA法补充的模式进行复检可以大大提高检测效率,保证及时有效地发现HIV感染者。较高S/CO值的标本感染HIV的可能性较大,且病毒处于复制活跃期具有较强感染性的可能性也较大。
Objective:To analyze the correlation between the re-inspection and confirmation for HIV-antibody preliminary screening positive samples. Method:ELISA and colloidal selenium assay were used to re-inspect preliminarily screening positive samples from Jan 2011 to Oct 2017,then the suspicious re-inspection positive samples were confirmed by Western blot. Results:There were 656 HIV-antibody preliminary screening positive samples in total,and 622 re-inspection samples were positive. The false positive rate of HIV-antibody preliminary screening was 5.2%(34/656). And 490 samples with complete information of the subjects were confirmed by Western blot,and 450 samples were positive(91.8%),11 samples were negative(2.3%),and 29 samples were uncertain(5.9%). The confirmed positive rate was 92.9%(450/488)in samples re-inspected by ELISA,and th econfirmed positive rate was 99.1%(450/454)in samples re-inspected by colloidal selenium assay(P<0.01). Compared with the S/CO>6 group,the confirmed positive rates of the 3≤ S/CO≤ 6 group and 1≤ S/CO<3 group in samples re-inspected by ELISA were significantly lower(P<0.01). The S/CO value was positively correlated with the number of bands of confirmed positive samples(P<0.01). Conclusion:Application of colloidal selenium assay combined with ELISA can greatly increase the confirmed positive rate.
引文
[1] Magiokinis G,Angelis K,Mamais I,et al. The global spread ofHIV-1 subtype B epidemic[J]. Infect Genet Evol,2016,46:169-179.
[2]黎锋,刘伟,梁富雄,等.2472例HIV抗体筛查(ELISA)与免疫印迹试验的对比研究[J].实用预防医学,2009,15(5):302-304.
[3]高赛珍,欧慧,师舞阳,等.HIV抗体筛查试验阳性样品的复检与确证结果分析[J].中国卫生检验杂志,2015,25(14):2408-2410.
[4]王晓敏,何军,唐荣.HIV抗体筛查阳性标本复检与确证结果分析[J].中国艾滋病性病,2015,21(9):821-822.
[5]魏微.辽阳市2011—2013年HIV抗体确证结果分析[J].中国公共卫生,2015,31(10):1359-1360.
[6]杨扬,郑海潮,于彤彤,等.746例HIV初筛阳性者确证结果的对比分析[J].热带医学杂志,2016,16(3):329-332.
[7]潘晶,韩秀云,关恒云,等.2009~2010年济南市379例HIV筛查阳性者的确证结果分析[J].预防医学论坛,2011,17(9):797-798.
[8]李广兵,罗燕,周爱华,等.HIV抗体筛查与确证(WB)实验结果分析[J].实用预防医学,2012,19(1):129-130.
[9]郭志宏,徐宝祥,严菊英,等.HIV初筛阳性标本确认试验结果分析[J].中国性病艾滋病防治,1997,3(3):116-117.
[10]王继宝,张娜,于海英,等.免疫印迹法带型作为判定HIV-1新发感染的研究[J].中华流行病学杂志,2013,34(10):998-1002.
[11]刘建敏,董雪,李欣,等.沈阳市2013年HIV抗体初筛阳性标本的复检及确证结果分析[J].中国卫生检验杂志,2015,25(6):844-845,851.
[12]高赛珍,欧慧,黄宗杰,等.500例HIV抗体筛查阳性样本确证检测[J].实用预防医学,2016,23(5):532-534.